AdaptHealth (AHCO) Competitors

AdaptHealth logo
$7.56 -0.17 (-2.21%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AHCO vs. YI, COSM, RDGT, MEDS, and HKPD

Should you buy AdaptHealth stock or one of its competitors? AdaptHealth's main competitors and comparable companies include 111 (YI), Cosmos Health (COSM), Ridgetech (RDGT), Wellgistics Health (MEDS), and Hong Kong Pharma Digital Technology (HKPD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does AdaptHealth compare to 111?

111 (NASDAQ:YI) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

111 has a net margin of -1.01% compared to AdaptHealth's net margin of -12.90%. 111's return on equity of 0.00% beat AdaptHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
111-1.01% N/A -4.86%
AdaptHealth -12.90%-0.27%-0.09%

111 has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than 111, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
111$1.80B0.01-$9.65M-$1.60N/A
AdaptHealth$3.24B0.33-$70.79M-$3.00N/A

In the previous week, AdaptHealth had 4 more articles in the media than 111. MarketBeat recorded 7 mentions for AdaptHealth and 3 mentions for 111. 111's average media sentiment score of 0.64 beat AdaptHealth's score of 0.27 indicating that 111 is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
111
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AdaptHealth
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

111 has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market.

AdaptHealth has a consensus target price of $9.43, indicating a potential upside of 21.97%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than 111.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
111
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
AdaptHealth
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

21.3% of 111 shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 43.9% of 111 shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

AdaptHealth beats 111 on 9 of the 15 factors compared between the two stocks.

How does AdaptHealth compare to Cosmos Health?

Cosmos Health (NASDAQ:COSM) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 26.2% of Cosmos Health shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

AdaptHealth has a net margin of -12.90% compared to Cosmos Health's net margin of -33.08%. AdaptHealth's return on equity of -0.27% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cosmos Health-33.08% -56.88% -18.03%
AdaptHealth -12.90%-0.27%-0.09%

AdaptHealth has a consensus target price of $9.43, indicating a potential upside of 21.97%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Cosmos Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
AdaptHealth
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

Cosmos Health has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cosmos Health$65.27M4.14-$19.15M-$12.80N/A
AdaptHealth$3.24B0.33-$70.79M-$3.00N/A

Cosmos Health has a beta of 4.73, indicating that its stock price is 373% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

In the previous week, AdaptHealth had 2 more articles in the media than Cosmos Health. MarketBeat recorded 7 mentions for AdaptHealth and 5 mentions for Cosmos Health. AdaptHealth's average media sentiment score of 0.27 beat Cosmos Health's score of 0.07 indicating that AdaptHealth is being referred to more favorably in the news media.

Company Overall Sentiment
Cosmos Health Neutral
AdaptHealth Neutral

Summary

AdaptHealth beats Cosmos Health on 11 of the 15 factors compared between the two stocks.

How does AdaptHealth compare to Ridgetech?

AdaptHealth (NASDAQ:AHCO) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

AdaptHealth has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market. Comparatively, Ridgetech has a beta of -0.17, suggesting that its stock price is 117% less volatile than the broader market.

Ridgetech has a net margin of 0.00% compared to AdaptHealth's net margin of -12.90%. Ridgetech's return on equity of 0.00% beat AdaptHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
AdaptHealth-12.90% -0.27% -0.09%
Ridgetech N/A N/A N/A

Ridgetech has lower revenue, but higher earnings than AdaptHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AdaptHealth$3.24B0.33-$70.79M-$3.00N/A
Ridgetech$132.16M0.03-$1.25MN/AN/A

82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 45.3% of Ridgetech shares are held by institutional investors. 2.0% of AdaptHealth shares are held by insiders. Comparatively, 22.6% of Ridgetech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, AdaptHealth had 6 more articles in the media than Ridgetech. MarketBeat recorded 7 mentions for AdaptHealth and 1 mentions for Ridgetech. Ridgetech's average media sentiment score of 1.79 beat AdaptHealth's score of 0.27 indicating that Ridgetech is being referred to more favorably in the news media.

Company Overall Sentiment
AdaptHealth Neutral
Ridgetech Very Positive

AdaptHealth currently has a consensus price target of $9.43, suggesting a potential upside of 21.97%. Given AdaptHealth's stronger consensus rating and higher probable upside, equities research analysts plainly believe AdaptHealth is more favorable than Ridgetech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdaptHealth
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
Ridgetech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

AdaptHealth beats Ridgetech on 8 of the 14 factors compared between the two stocks.

How does AdaptHealth compare to Wellgistics Health?

Wellgistics Health (NASDAQ:MEDS) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

AdaptHealth has a net margin of -12.90% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat AdaptHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
Wellgistics Health-1,100.16% N/A -171.81%
AdaptHealth -12.90%-0.27%-0.09%

AdaptHealth has a consensus price target of $9.43, suggesting a potential upside of 21.97%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts plainly believe AdaptHealth is more favorable than Wellgistics Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wellgistics Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
AdaptHealth
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

AdaptHealth has higher revenue and earnings than Wellgistics Health. AdaptHealth is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellgistics Health$23.34M0.09-$101.28M-$20.41N/A
AdaptHealth$3.24B0.33-$70.79M-$3.00N/A

5.7% of Wellgistics Health shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 19.5% of Wellgistics Health shares are held by insiders. Comparatively, 2.0% of AdaptHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Wellgistics Health has a beta of -3.14, indicating that its stock price is 414% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

In the previous week, AdaptHealth had 3 more articles in the media than Wellgistics Health. MarketBeat recorded 7 mentions for AdaptHealth and 4 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 0.55 beat AdaptHealth's score of 0.27 indicating that Wellgistics Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Wellgistics Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
AdaptHealth
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

AdaptHealth beats Wellgistics Health on 12 of the 15 factors compared between the two stocks.

How does AdaptHealth compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to AdaptHealth's net margin of -12.90%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat AdaptHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
AdaptHealth -12.90%-0.27%-0.09%

Hong Kong Pharma Digital Technology has a beta of 2.56, indicating that its stock price is 156% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

82.7% of AdaptHealth shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than AdaptHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$13.43M0.10-$1.14MN/AN/A
AdaptHealth$3.24B0.33-$70.79M-$3.00N/A

In the previous week, AdaptHealth had 3 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 7 mentions for AdaptHealth and 4 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.19 beat AdaptHealth's score of 0.27 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hong Kong Pharma Digital Technology
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AdaptHealth
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

AdaptHealth has a consensus price target of $9.43, suggesting a potential upside of 21.97%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Hong Kong Pharma Digital Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
AdaptHealth
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

AdaptHealth beats Hong Kong Pharma Digital Technology on 8 of the 14 factors compared between the two stocks.

Get AdaptHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AHCO vs. The Competition

MetricAdaptHealthHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.03B$10.57B$7.73B$11.61B
Dividend YieldN/A2.54%2.46%4.43%
P/E Ratio-2.5235.8034.1629.83
Price / Sales0.322.088.475.65
Price / Cash1.8823.3421.9322.50
Price / Book0.843.594.373.65
Net Income-$70.79M$332.46M$3.52B$392.18M
7 Day Performance-2.09%-4.09%-5.48%-4.27%
1 Month Performance25.56%-1.81%-4.62%-6.75%
1 Year Performance-18.98%18.67%-1.57%-7.22%

AdaptHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AHCO
AdaptHealth
2.6075 of 5 stars
$7.56
-2.2%
$9.43
+24.7%
-15.9%$1.03B$3.24BN/A10,900
YI
111
0.6057 of 5 stars
$3.05
+4.2%
N/A-28.8%$26.85M$1.80BN/A1,063
COSM
Cosmos Health
1.5072 of 5 stars
$0.21
-22.7%
N/A-82.8%$21.13M$65.27MN/A163
RDGT
Ridgetech
0.3551 of 5 stars
$1.07
-5.3%
N/A-99.8%$3.88M$132.16MN/A64
MEDS
Wellgistics Health
0.6096 of 5 stars
$0.96
-2.5%
N/A-98.0%$3.07M$23.34MN/A31

Related Companies and Tools


This page (NASDAQ:AHCO) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners